373 related articles for article (PubMed ID: 26397003)
1. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.
Nett JE; R Andes D
Microbiol Spectr; 2015 Jun; 3(3):E30. PubMed ID: 26397003
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity against Candida biofilms.
Iñigo M; Pemán J; Del Pozo JL
Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
[TBL] [Abstract][Full Text] [Related]
3. Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.
Muakkassa FK; Ghannoum M
Adv Exp Med Biol; 2016; 931():95-103. PubMed ID: 27287466
[TBL] [Abstract][Full Text] [Related]
4. Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation.
Lee JA; Robbins N; Xie JL; Ketela T; Cowen LE
PLoS Genet; 2016 Nov; 12(11):e1006452. PubMed ID: 27870871
[TBL] [Abstract][Full Text] [Related]
5. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence imaging of fungal biofilm development in live animals.
Vande Velde G; Kucharíková S; Van Dijck P; Himmelreich U
Methods Mol Biol; 2014; 1098():153-67. PubMed ID: 24166376
[TBL] [Abstract][Full Text] [Related]
7. Host contributions to construction of three device-associated Candida albicans biofilms.
Nett JE; Zarnowski R; Cabezas-Olcoz J; Brooks EG; Bernhardt J; Marchillo K; Mosher DF; Andes DR
Infect Immun; 2015 Dec; 83(12):4630-8. PubMed ID: 26371129
[TBL] [Abstract][Full Text] [Related]
8. Recent insights into Candida albicans biofilm resistance mechanisms.
Mathé L; Van Dijck P
Curr Genet; 2013 Nov; 59(4):251-64. PubMed ID: 23974350
[TBL] [Abstract][Full Text] [Related]
9. Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
[TBL] [Abstract][Full Text] [Related]
10. Bioluminescence Imaging to Study Mature Biofilm Formation by Candida spp. and Antifungal Activity In Vitro and In Vivo.
Van Dyck K; Van Dijck P; Vande Velde G
Methods Mol Biol; 2020; 2081():127-143. PubMed ID: 31721122
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.
Madariaga-Venegas F; Fernández-Soto R; Duarte LF; Suarez N; Delgadillo D; Jara JA; Fernández-Ramires R; Urzúa B; Molina-Berríos A
PLoS One; 2017; 12(5):e0176755. PubMed ID: 28493889
[TBL] [Abstract][Full Text] [Related]
12. Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis.
Yano J; Yu A; Fidel PL; Noverr MC
PLoS One; 2016; 11(7):e0159692. PubMed ID: 27453977
[TBL] [Abstract][Full Text] [Related]
13. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.
Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K
J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Candida albicans biofilm.
Tsui C; Kong EF; Jabra-Rizk MA
Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
[TBL] [Abstract][Full Text] [Related]
15. Candida biofilm: a well-designed protected environment.
Mukherjee PK; Zhou G; Munyon R; Ghannoum MA
Med Mycol; 2005 May; 43(3):191-208. PubMed ID: 16010846
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
[TBL] [Abstract][Full Text] [Related]
18. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans biofilm heterogeneity does not influence denture stomatitis but strongly influences denture cleansing capacity.
O'Donnell LE; Alalwan HKA; Kean R; Calvert G; Nile CJ; Lappin DF; Robertson D; Williams C; Ramage G; Sherry L
J Med Microbiol; 2017 Jan; 66(1):54-60. PubMed ID: 28032543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
